Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | APAF1 | O14727 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20719879 | 0.89 | MEN1 (0.43) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Bromide SCHEMBL20558747 | 0.87 | MEN1 (0.46) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| SCHEMBL18155009 | 0.87 | MEN1 (0.38) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Bromide SCHEMBL15312087 | 0.86 | MEN1 (0.30) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Bromide SCHEMBL28944094 | 0.86 | MEN1 (0.30) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL5671859 | 0.86 | — | — | |
| Bromide SCHEMBL30788 | 0.82 | MEN1 (0.50) | MEN1APAF1NPC1PLA2G1BHSP90AA1 | |
| SCHEMBL534312 | 0.82 | CYP3A4 (0.30) | — | |
| SCHEMBL5718742 | 0.82 | — | — | |
| SCHEMBL3989906 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230098502-A1 | Use Of Ionic Polymers For Hydrolysis Of Proteins And Protein-Containing Feedstock | EMBION TECHNOLOGIES SA (CH) | 2023-03-30 | — | — | US | disclosed |
| US-20200246785-A1 | IONIC POLYMERS AND USE THEREOF IN BIOMASS PROCESSING | EMBION TECHNOLOGIES SA (CH) | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098502-A1 | Use Of Ionic Polymers For Hydrolysis Of Proteins And Protein-Containing Feedstock | IDE, LCT, IAPP | MEN1 3755/4885APAF1 714/4885NPC1 4654/4885 |
| US-20200246785-A1 | IONIC POLYMERS AND USE THEREOF IN BIOMASS PROCESSING | IPMK, INPP5A, MPI | MEN1 2969/4885APAF1 3417/4885NPC1 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.